Skip to content

Belgian healthtech startup IntelliProve raises €2.7M to bring facial health scans into hum

·StartupReader editorial desk· 2 min readReviewed by our editors

Belgian healthtech startup IntelliProve has secured €2.7 million in seed funding to adapt its facial health monitoring technology for use in humanoid robots. Led by Miles Ahead, the round also includes investments from home nursing organization Wit-Gele Kruis, the imec.istart Fund, and several business angels. The company’s software analyzes heart rate, heart rate variability (HRV), breathing patterns, and blood pressure from a 30-second facial scan using only a standard camera, eliminating the need for traditional cuff-based measurements.

The funding reflects a deliberate push into robotics, where the demand for built-in health diagnostics is rising. IntelliProve’s technology is already integrated into health and wellness apps used in over 50 countries, but the company now aims to make it a standard feature in humanoid robots deployed in care settings. The investment will be divided among regulatory efforts, research, and commercial expansion—including partnerships with robotics firms.

The underlying technology, remote photoplethysmography (rPPG), detects minuscule color shifts in facial skin linked to blood flow. IntelliProve’s deep-learning model then estimates blood pressure by analyzing pulse wave patterns, with validation based on over 6 million data points. While the company hasn’t disclosed exact accuracy metrics for blood pressure, internal tests show its heart rate readings typically match reference devices within a narrow margin.

IntelliProve already holds a CE mark for its core signal acquisition technology under EU medical device regulations and is working toward broader certification. The funding will also support expanded data collection across diverse demographics, lighting conditions, and devices—a critical step for improving reliability.

The move aligns with broader trends in humanoid robotics, where recent funding rounds for companies like Agile Robots and Minerva Humanoids signal growing investor interest in care-assistant robots. By integrating IntelliProve’s health monitoring, these robots could perform passive checks during interactions and relay results to caregivers or telehealth systems, potentially reducing the need for additional hardware.

The company’s success will depend on two key factors. First, whether its blood pressure estimates can meet clinical standards for broader adoption. Second, whether robotics firms adopt the technology as a core feature rather than an optional add-on. IntelliProve’s existing partnerships with unnamed robotics companies may determine its trajectory, but the €2.7 million round reflects a broader bet on AI-driven diagnostics embedded in physical interfaces—a shift that could reshape remote health monitoring beyond digital screens.

Sources: thenextweb.com

“This €2.7M round signals a shift toward embedding AI-driven health monitoring directly into physical robots—a move that could streamline eldercare and telehealth by removing the need for separate diagnostic tools.”
— StartupReader
ShareLinkedInXWhatsApp

One of the funding rounds reported in the week of 16–22 November 2026. See every round that week.

Read the original reporting

The outlets below did the original reporting.

Related briefs

This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.